These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 25845131)

  • 21. Use of the chromogenic factor X assay in patients transitioning from argatroban to warfarin therapy.
    Austin JH; Stearns CR; Winkler AM; Paciullo CA
    Pharmacotherapy; 2012 Jun; 32(6):493-501. PubMed ID: 22511112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reinitiating warfarin: relationships between dose and selected patient, clinical and hospital measures.
    Leonhard LG; Berg RL; Burmester JK; Mazza JJ; Schmelzer JR; Yale SH
    Clin Med Res; 2015 Mar; 13(1):1-6. PubMed ID: 24899695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of soy milk on warfarin efficacy.
    Cambria-Kiely JA
    Ann Pharmacother; 2002 Dec; 36(12):1893-6. PubMed ID: 12452752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between warfarin dosage and international normalized ratio: a dose-response analysis and evaluation based on multicenter data.
    Xue L; Zhang Y; Xie C; Zhou L; Liu L; Zhang H; Xu L; Song H; Lin M; Qiu H; Zhu J; Zhu Y; Zou J; Zhuang W; Xuan B; Chen Y; Fan Y; Wu D; Shen Z; Miao L
    Eur J Clin Pharmacol; 2019 Jun; 75(6):785-794. PubMed ID: 31037455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a Predictive Nomogram for the Change in PT/INR Upon Discontinuation of Bivalirudin as a Bridge to Warfarin.
    Hohlfelder B; DeiCicchi D; Sylvester KW; Connors JM
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):487-493. PubMed ID: 26994297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Study on Drug Interaction between Warfarin and Capecitabine with Special Reference to the Co-Administered Term or the Discontinuation Term of Capecitabine.
    Ikenishi M; Ueda M; Kuroda A; Tsukazaki H; Nakao M; Takeuchi M; Konishi Y; Matsuda T; Figoni W; Ohtori T; Matsuyama K; Satoh H; Sawada Y; Nakatsuka E
    Gan To Kagaku Ryoho; 2015 Jul; 42(7):833-9. PubMed ID: 26197745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pilot study of the association of pharmacokinetic and pharmacodynamic parameters of warfarin with the dose in patients on long-term anticoagulation.
    Kulkarni UP; Swar BD; Karnad DR; Davis S; Patwardhan AM; Kshirsagar NA; Gogtay NJ
    Br J Clin Pharmacol; 2008 May; 65(5):787-90. PubMed ID: 18294321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management.
    Eljilany I; Elarref M; Shallik N; Elzouki AN; Bader L; El-Bardissy A; Abdelsamad O; Al-Badriyeh D; Cavallari LH; Elewa H
    Pharmgenomics Pers Med; 2021; 14():1069-1080. PubMed ID: 34483679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective evaluation of a bivalirudin to warfarin transition nomogram.
    Hohlfelder B; Sylvester KW; Rimsans J; DeiCicchi D; Connors JM
    J Thromb Thrombolysis; 2017 May; 43(4):498-504. PubMed ID: 28102475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bridging for an isolated subtherapeutic INR: an evaluation of clinical practice patterns, outcomes, and costs from an anticoagulation clinic.
    Hwang JM; Taylor TN; Sharma KP; Clemente JL; Garwood CL
    J Thromb Thrombolysis; 2012 Jan; 33(1):28-37. PubMed ID: 21960323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clotting-Factor Concentrations 5 Days After Discontinuation of Warfarin.
    Benzon HT; Asher Y; Kendall MC; Vida L; McCarthy RJ; Green D
    Reg Anesth Pain Med; 2018 Aug; 43(6):616-620. PubMed ID: 29659439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of an algorithm to predict decline in INR following warfarin cessation in patients undergoing invasive procedures.
    Kampouraki E; Wynne H; Avery P; Kamali F
    J Thromb Thrombolysis; 2020 May; 49(4):630-635. PubMed ID: 31848875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative Systems Pharmacology Model-Based Predictions of Clinical Endpoints to Optimize Warfarin and Rivaroxaban Anti-Thrombosis Therapy.
    Hartmann S; Biliouris K; Lesko LJ; Nowak-Göttl U; Trame MN
    Front Pharmacol; 2020; 11():1041. PubMed ID: 32765265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporary discontinuation of warfarin therapy: changes in the international normalized ratio.
    White RH; McKittrick T; Hutchinson R; Twitchell J
    Ann Intern Med; 1995 Jan; 122(1):40-2. PubMed ID: 7985894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized trial of restarting warfarin at maintenance versus loading doses following an elective procedure.
    Bungard TJ; Mutch J; Ritchie B
    J Thromb Thrombolysis; 2017 Nov; 44(4):507-515. PubMed ID: 28914415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzalutamide-warfarin interaction necessitating warfarin dosage adjustment: A case report of successful clinical management.
    Parrett JL; Reaves AB; Self TH; Owens RE
    J Clin Pharm Ther; 2018 Apr; 43(2):276-279. PubMed ID: 28901605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Bivalirudin's Effect on International Normalized Ratio to Determine an Appropriate Strategy for Transitioning to Warfarin.
    Fetea A; Gulbis BE; Hall AC
    J Pharm Technol; 2018 Jun; 34(3):117-122. PubMed ID: 34860995
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study.
    Schulman S; Elbazi R; Zondag M; O'Donnell M
    Thromb J; 2008 Oct; 6():15. PubMed ID: 18925967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffuse Alveolar Hemorrhage Caused by Warfarin after Rifampicin Discontinuation.
    Kiyota T; Shiota S; Hamanaka R; Tsutsumi D; Takakura T; Miyazaki E
    Case Rep Med; 2019; 2019():4917856. PubMed ID: 30809261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of Vitamin D Status on the Maintenance Dose of Warfarin in Patients Receiving Chronic Warfarin Therapy.
    Khansari N; Bagheri M; Homayounfar S; Poorolajal J; Mehrpooya M
    Cardiol Ther; 2022 Sep; 11(3):421-432. PubMed ID: 35718837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.